Literature DB >> 1747118

Synthesis and secretion of a cobalamin-binding protein by HT 29 cell line.

H Schohn1, J L Guéant, M Girr, E Nexø, L Baricault, A Zweibaum, J P Nicolas.   

Abstract

An HT 29 cell line derived from human colonic carcinoma was shown to synthesize and release a cobalamin-binding protein. The cobalamin-binding protein was classified as transcobalamin (TC). By gel filtration on Sephacryl S200 HR, we observed that the secreted protein bound to cobalamin had the same size as plasma transcobalamin. Like transcobalamin, the cobalamin-binding protein bound cobalamin but not cobinamide. Purification of the cobalamin-binding protein was performed by heparin-Sepharose affinity chromatography and by Sephacryl S200 gel filtration. The molecular mass of the purified protein was estimated at 44 kDa by SDS/PAGE. The isoelectric point was determined to be 6.4. The purified cobalamin-binding protein reacted with an antiserum produced against human transcobalamin. A 44 kDa band was also identified by SDS/PAGE of an immunoprecipitated homogenate from HT 29 cells labelled with [35S]methionine and in a Western blot of cell homogenates. The secretion of the cobalamin-binding protein was maximal between 10 and 12 days of cell culture and was inhibited by cycloheximide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747118      PMCID: PMC1130565          DOI: 10.1042/bj2800427

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Binding of vitamin B12--rat transcobalamin II and free vitamin B12 to plasma membranes isolated from rat liver.

Authors:  C Fiedler-Nagy; G R Rowley; J W Coffey; O N Miller
Journal:  Br J Haematol       Date:  1975-11       Impact factor: 6.998

2.  Human umbilical vein endothelial cells secrete transcobalamin II.

Authors:  R Carmel; S M Neely; R B Francis
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

3.  Formation of transcobalamin II--vitamin B12 complex by guinea-pig ileal mucosa in organ culture after in vivo incubation with intrinsic factor--vitamin B12.

Authors:  S P Rothenberg; J P Weiss; R Cotter
Journal:  Br J Haematol       Date:  1978-11       Impact factor: 6.998

4.  Vitamin B 12 binding proteins in the human embryo.

Authors:  D W Sonneborn; M J Iwanik; H J Hansen
Journal:  Proc Soc Exp Biol Med       Date:  1974-02

5.  Purification and characterization of rabbit transcobalamin II.

Authors:  E Nexo; H Olesen; D Bucher; J Thomsen
Journal:  Biochim Biophys Acta       Date:  1977-10-26

6.  Evidence for intestinal origin of transcobalamin II during vitamin B12 absorption.

Authors:  I Chanarin; M Muir; A Hughes; A V Hoffbrand
Journal:  Br Med J       Date:  1978-06-03

7.  Synthesis and secretion of the human vitamin B12-binding protein, transcobalamin II, by cultured skin fibroblasts and by bone marrow cells.

Authors:  M Fràter-Schröder; H J Porck; J Erten; M R Müller; B Steinmann; L Kierat; F Arwert
Journal:  Biochim Biophys Acta       Date:  1985-06-30

8.  Characterization of the particulate and soluble acceptor for transcobalamin II from human placenta and rabbit liver.

Authors:  E Nexø; M D Hollenberg
Journal:  Biochim Biophys Acta       Date:  1980-03-03

9.  Binding and uptake of transcobalamin II by human fibroblasts.

Authors:  P Youngdahl-Turner; L E Rosenberg; R H Allen
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

10.  Uptake and metabolism of free cyanocobalamin by cultured human fibroblasts from controls and a patient with transcobalamin II deficiency.

Authors:  N Berliner; L E Rosenberg
Journal:  Metabolism       Date:  1981-03       Impact factor: 8.694

View more
  7 in total

1.  Immunohistochemical quantification of the vitamin B12 transport protein (TCII), cell surface receptor (TCII-R) and Ki-67 in human tumor xenografts.

Authors:  Annette M Sysel; Victor E Valli; Ray B Nagle; Joseph A Bauer
Journal:  Anticancer Res       Date:  2013-10       Impact factor: 2.480

2.  Pharmacokinetics of intravenous nitrosylcobalamin, an antitumor agent, in healthy Beagle dogs: a pilot study.

Authors:  Annette M Sysel; Walter I Horne; Jörg M Steiner; Jan S Suchodolski; Joseph A Bauer
Journal:  Anticancer Res       Date:  2012-09       Impact factor: 2.480

3.  Intrinsic factor receptor during fetal development of the human intestine.

Authors:  H Schohn; J L Guéant; B Leheup; M Saunier; G Grignon; J P Nicolas
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

4.  Transcellular transport of cobalamin in aortic endothelial cells.

Authors:  Luciana Hannibal; Keerthana Bolisetty; Armend Axhemi; Patricia M DiBello; Edward V Quadros; Sergey Fedosov; Donald W Jacobsen
Journal:  FASEB J       Date:  2018-05-09       Impact factor: 5.191

5.  Targeting receptors, transporters and site of absorption to improve oral drug delivery.

Authors:  J H Hamman; P H Demana; E I Olivier
Journal:  Drug Target Insights       Date:  2007-03-06

6.  Uptake and transport of B12-conjugated nanoparticles in airway epithelium.

Authors:  Robyn Fowler; Driton Vllasaliu; Franco H Falcone; Martin Garnett; Bryan Smith; Helen Horsley; Cameron Alexander; Snow Stolnik
Journal:  J Control Release       Date:  2013-09-02       Impact factor: 9.776

7.  Assessment of cellular cobalamin metabolism in Gaucher disease.

Authors:  Suelen Porto Basgalupp; Marina Siebert; Charles Ferreira; Sidney Behringer; Ute Spiekerkoetter; Luciana Hannibal; Ida Vanessa Doederlein Schwartz
Journal:  BMC Med Genet       Date:  2020-01-13       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.